Journal for ImmunoTherapy of Cancer (Jan 2022)
Fc-null anti-PD-1 monoclonal antibodies deliver optimal checkpoint blockade in diverse immune environments
- C Ian Mockridge,
- H T Claude Chan,
- Mark S Cragg,
- Jinny Kim,
- Tatyana Inzhelevskaya,
- Jane E Willoughby,
- Julia Moreno-Vicente,
- Martin C Taylor,
- Steven G Booth,
- Vikki L English,
- Emily L Williams,
- Christine A Penfold,
- Juliet C Gray,
- Stephen A Beers
Affiliations
- C Ian Mockridge
- Antibody and Vaccine Group, Centre for Cancer Immunology, Cancer Sciences Unit, Faculty of Medicine, University of Southampton, Southampton, UK
- H T Claude Chan
- 1 Antibody & Vaccine Group, Centre for Cancer Immunology, Cancer Sciences Unit, Faculty of Medicine, University of Southampton, Southampton, Hampshire, UK
- Mark S Cragg
- Antibody and Vaccine Group, Centre for Cancer Immunology, Cancer Sciences Unit, Faculty of Medicine, University of Southampton, Southampton, UK
- Jinny Kim
- Antibody and Vaccine Group, Centre for Cancer Immunology, Cancer Sciences Unit, Faculty of Medicine, University of Southampton, Southampton, UK
- Tatyana Inzhelevskaya
- Antibody and Vaccine Group, Centre for Cancer Immunology, Cancer Sciences Unit, Faculty of Medicine, University of Southampton, Southampton, UK
- Jane E Willoughby
- Antibody and Vaccine Group, Centre for Cancer Immunology, Cancer Sciences Unit, Faculty of Medicine, University of Southampton, Southampton, UK
- Julia Moreno-Vicente
- Antibody and Vaccine Group, Centre for Cancer Immunology, Cancer Sciences, University of Southampton, Southampton, UK
- Martin C Taylor
- Antibody and Vaccine Group, Centre for Cancer Immunology, Cancer Sciences, University of Southampton, Southampton, UK
- Steven G Booth
- Antibody and Vaccine Group, Centre for Cancer Immunology, Cancer Sciences, University of Southampton, Southampton, UK
- Vikki L English
- Antibody and Vaccine Group, Centre for Cancer Immunology, Cancer Sciences, University of Southampton, Southampton, UK
- Emily L Williams
- Antibody and Vaccine Group, Centre for Cancer Immunology, Cancer Sciences, University of Southampton, Southampton, UK
- Christine A Penfold
- Antibody and Vaccine Group, Centre for Cancer Immunology, Cancer Sciences, University of Southampton, Southampton, UK
- Juliet C Gray
- Antibody and Vaccine Group, Centre for Cancer Immunology, Cancer Sciences, University of Southampton, Southampton, UK
- Stephen A Beers
- Antibody and Vaccine Group, Centre for Cancer Immunology, Cancer Sciences, University of Southampton, Southampton, UK
- DOI
- https://doi.org/10.1136/jitc-2021-003735
- Journal volume & issue
-
Vol. 10,
no. 1
Abstract
No abstracts available.